Cargando…

New year, new SARS-CoV-2 variant: Resolutions on genomic surveillance protocols to face Omicron

Detalles Bibliográficos
Autores principales:	Oróstica, Karen Y., Contreras, Sebastian, Sanchez-Daza, Anamaria, Fernandez, Jorge, Priesemann, Viola, Olivera-Nappa, Álvaro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8837806/ https://www.ncbi.nlm.nih.gov/pubmed/35187522 http://dx.doi.org/10.1016/j.lana.2022.100203

Ejemplares similares

Rethinking COVID-19 vaccine allocation: it is time to care about our neighbours
por: Contreras, Sebastian, et al.
Publicado: (2021)

From emergency response to long-term management: the many faces of the endemic state of COVID-19
por: Contreras, Seba, et al.
Publicado: (2023)

Risking further COVID-19 waves despite vaccination
por: Contreras, Sebastian, et al.
Publicado: (2021)

Relaxing restrictions at the pace of vaccination increases freedom and guards against further COVID-19 waves
por: Bauer, Simon, et al.
Publicado: (2021)

Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic
por: Karim, Salim S Abdool, et al.
Publicado: (2021)

Omicron: fewer adverse outcomes come with new dangers
por: Post, Lori Ann, et al.
Publicado: (2022)

On the heterogeneous spread of COVID-19 in Chile
por: Freire-Flores, Danton, et al.
Publicado: (2021)

Could Beta variant containing COVID-19 booster vaccines tackle Omicron variants?
por: Jin, Pengfei, et al.
Publicado: (2023)

Effectiveness of mRNA booster doses against the omicron variant
por: Zedan, Hadeel T, et al.
Publicado: (2022)

Total mutational load and clinical features as predictors of the metastatic status in lung adenocarcinoma and squamous cell carcinoma patients
por: Oróstica, Karen Y., et al.
Publicado: (2022)

COVID-19 vaccine effectiveness against the omicron (BA.2) variant in England
por: Kirsebom, Freja C M, et al.
Publicado: (2022)

The potential of Beta variant containing COVID booster vaccines for chasing Omicron in 2022
por: Sridhar, Saranya, et al.
Publicado: (2022)

Lower risk of Multi-system inflammatory syndrome in children (MIS-C) with the omicron variant
por: Lopez, Laura, et al.
Publicado: (2022)

Vaccination and protective immunity to SARS-CoV-2 omicron variants in people with immunodeficiencies
por: Nadesalingam, Angalee, et al.
Publicado: (2023)

Neutralizing antibodies and their cocktails against SARS-CoV-2 Omicron and other circulating variants
por: Yang, Yang, et al.
Publicado: (2022)

Omicron breakthrough infections in patients with immune-mediated inflammatory diseases
por: Liew, Jean W, et al.
Publicado: (2022)

Shedding new light on COVID-19 therapeutics during the omicron era: a deeper dive into real-world data
por: De Vito, Andrea, et al.
Publicado: (2023)

Omicron severity: milder but not mild
por: Nealon, Joshua, et al.
Publicado: (2022)

Omicron in pregnancy: time to breathe easier?
por: Auger, Nathalie, et al.
Publicado: (2022)

Real-world effectiveness of nirmatrelvir–ritonavir against BA.4 and BA.5 omicron SARS-CoV-2 variants
por: Wong, Carlos K H, et al.
Publicado: (2023)

Updated report of COVID-19 vaccine safety monitoring in Japan: booster doses for Omicron variants and vaccinations for infants and young children
por: Yamaguchi, Toshihiro, et al.
Publicado: (2023)

What do we know about pathological mechanism and pattern of lung injury related to SARS-CoV-2 Omicron variant?
por: Scendoni, Roberto, et al.
Publicado: (2023)

Omicron infection milder in nursing home residents
por: Katz, Morgan J, et al.
Publicado: (2022)

Prioritisation of COVID-19 boosters in the omicron era
por: Irving, Stephanie A, et al.
Publicado: (2022)

Genomic surveillance of SARS-CoV-2 upsurge in India due to Omicron sub-lineages BA.2.74, BA.2.75 and BA.2.76
por: Singh, Urvashi B., et al.
Publicado: (2023)

Milder disease with Omicron: is it the virus or the pre-existing immunity?
por: Sigal, Alex
Publicado: (2022)

A Novel Synthetic Model of the Glucose-Insulin System for Patient-Wise Inference of Physiological Parameters From Small-Size OGTT Data
por: Contreras, Sebastián, et al.
Publicado: (2020)

Development of Supervised Learning Predictive Models for Highly Non-linear Biological, Biomedical, and General Datasets
por: Medina-Ortiz, David, et al.
Publicado: (2020)

Antigenic evolution will lead to new SARS-CoV-2 variants with unpredictable severity
por: Markov, Peter V., et al.
Publicado: (2022)

Peptipedia: a user-friendly web application and a comprehensive database for peptide research supported by Machine Learning approach
por: Quiroz, Cristofer, et al.
Publicado: (2021)

COVID-19 vaccine boosters in the Asia-Pacific region in the context of Omicron
por: Hart, John D, et al.
Publicado: (2022)

Omicron: A new face of COVID‐19 pandemic
por: Khan, Amjad, et al.
Publicado: (2022)

Welcome editorial by the new CKJ Editor-in-Chief: Facing the future of CKJ with enthusiasm!
por: Soler, María José
Publicado: (2022)

World Facing the latest variant of Concern---------Omicron
por: Javaid, Muhammad Mohsin, et al.
Publicado: (2022)

Global emergence of SARS-CoV-2 variants: new foresight needed for improved vaccine efficacy
por: Yadav, Pragya D, et al.
Publicado: (2022)

Transmission of Omicron (B.1.1.529) - SARS-CoV-2 Variant of Concern in a designated quarantine hotel for travelers: a challenge of elimination strategy of COVID-19
por: Wong, Shuk-Ching, et al.
Publicado: (2021)

Pathogenicity of SARS-CoV-2 Omicron BA.1.1 in hamsters
por: Chan, Jasper Fuk-Woo, et al.
Publicado: (2022)

Estimating disease severity of Omicron and Delta SARS-CoV-2 infections
por: Sigal, Alex, et al.
Publicado: (2022)

SARS-CoV-2 spread and hospitalisations in paediatric patients during the omicron surge
por: Belay, Ermias D, et al.
Publicado: (2022)

The benefit of vaccination after previous SARS-CoV-2 infection in the omicron era
por: Boaventura, Viviane S, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4p1cabrrl6rhhevmfgs8fcoh6j